

| Package | Price per Dose | Price | |
|---|---|---|---|
| 350 pills | £0.45 | £176.69 £159.02 Free shipping | |
| 140 pills | £0.50 | £78.24 £70.42 | |
| 84 pills | £0.57 | £53.00 £47.70 | |
| 56 pills | £0.62 | £39.11 £35.20 | |
| 28 pills | £0.69 | £21.44 £19.30 | |
| 14 pills | £0.90 | £13.87 £12.48 | |
| 350 pills | £0.49 | £190.58 £171.52 Free shipping | |
| 140 pills | £0.53 | £83.29 £74.96 | |
| 98 pills | £0.59 | £64.36 £57.92 | |
| 84 pills | £0.66 | £61.83 £55.65 | |
| 56 pills | £0.73 | £45.43 £40.88 | |
| 28 pills | £0.81 | £25.23 £22.71 | |
| 14 pills | £1.06 | £16.40 £14.76 | |
| 350 pills | £0.60 | £234.75 £211.28 Free shipping | |
| 140 pills | £0.67 | £104.75 £94.27 | |
| 84 pills | £0.76 | £70.67 £63.60 | |
| 56 pills | £0.83 | £51.74 £46.56 | |
| 28 pills | £0.93 | £29.02 £26.12 | |
| 14 pills | £1.14 | £17.66 £15.89 |
Atenolol, a cardioselective beta-1 adrenergic blocker introduced in the 1970s, is widely prescribed for hypertension and ischemic heart disease. It acts by dampening sympathetic stimulation of the heart, lowering heart rate and reducing myocardial oxygen demand.
It binds selectively to beta-1 receptors in cardiac tissue, decreasing heart rate, contractility, and AV nodal conduction. Renin release from juxtaglomerular cells is diminished, contributing to reduced systemic vascular resistance and blood pressure.
Pharmacokinetically, atenolol is relatively hydrophilic with limited central nervous system penetration and is predominantly eliminated unchanged by the kidneys. The half-life supports once-daily dosing for many patients, though adjustments may be needed for renal impairment.
Hypertension remains a principal indication, used alone or in combination with other antihypertensives to reduce cardiovascular risk. It is also employed as part of multi‑drug regimens to achieve target blood pressure in patients with comorbid conditions.
In stable angina pectoris, atenolol lowers myocardial oxygen demand and heart rate, improving exercise tolerance and reducing anginal episodes. It is beneficial in reducing ischemic episodes during exertion or stress testing.
Postinfarction management and certain tachyarrhythmias are treated with atenolol to decrease arrhythmia burden and mortality risk in selected populations, including after myocardial infarction under guideline-directed care.
Atenolol is administered orally as 25 mg, 50 mg, and 100 mg tablets. Dosing is individualized based on indication, response, and tolerability, with regular clinical monitoring.
For hypertension, regimens commonly begin at 25 mg daily, titrating to 50 mg or 100 mg daily as needed and tolerated. For stable angina, similar titration is used according to symptom control and blood pressure targets.
The drug may be given once daily due to its duration of action in many patients; however, divided dosing can be employed under specialist supervision. It may be taken with or without food as directed.
Contraindications include overt heart failure, second- or third-degree AV block, severe bradycardia, sick sinus syndrome without a pacemaker, and hypersensitivity to beta-blockers.
Caution is warranted in bronchospastic disease, diabetes mellitus, peripheral vascular disease, and in pregnancy or lactation. Abrupt withdrawal may worsen ischemia or provoke tachyarrhythmia or rebound hypertension.
Drug interactions with non-dihydropyridine calcium channel blockers, clonidine withdrawal, or other agents causing bradycardia require careful monitoring and possible dose adjustment.
Most patients experience fatigue, dizziness, bradycardia, and cold extremities. Some report sleep disturbances or vivid dreams, though this is less common than with lipophilic beta-blockers.
Gastrointestinal symptoms such as nausea or dry mouth may occur. Sexual dysfunction, reduced exercise tolerance, and masking of hypoglycemia signs can affect select individuals, particularly those with diabetes mellitus.
Serious adverse events are uncommon but include high-grade bradycardia, hypotension, heart block, bronchospasm in susceptible individuals, and signs of congestive heart failure. Seek medical advice if symptoms worsen or persist.
14–21 days. Free from £151.46 .
5–9 days. £22.72
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
